-+ 0.00%
-+ 0.00%
-+ 0.00%

Curiox Biosystems Q3 Net Loss Widens to KRW 5.35 Billion

PUBT·10/27/2026 09:17:07
Curiox Biosystems Q3 Net Loss Widens to KRW 5.35 Billion
  • Curiox Biosystems posted a third-quarter 2026 operating loss of KRW 3.96 billion, widening 47.76% year over year.
  • Revenue rose 7.73% from a year earlier to KRW 1.49 billion.
  • Net loss widened 76.57% year over year to KRW 5.35 billion.
  • For January-September 2026, revenue increased 20.93% to KRW 3.99 billion.
  • Nine-month net loss narrowed 48.48% to KRW 12.83 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curiox Biosystems Co., Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261027900676), on October 27, 2026, and is solely responsible for the information contained therein.